Preferred Label : Study Agent Expanded Access Indicator;
NCIt related terms : StudyAgent.expandedAccessIndicator;
Alternative definition : BRIDG 5.3: Specifies whether the product (drug or device) is available for patients
who are not adequately treated by existing therapy, who do not meet the eligibility
criteria for enrollment, or who are otherwise unable to participate in a controlled
study. Expanded Access is a mechanism that provides non-protocol access to experimental
treatments, including protocol exception, single-patient IND, treatment IND, compassionate
use, emergency use, continued access and parallel track. EXAMPLE(S): OTHER NAME(S):
NOTE(S):;
NCI Metathesaurus CUI : CL978330;
Origin ID : C165125;
UMLS CUI : C5236914;
Semantic type(s)
- concept_is_in_subset
